Clinical Pharmacology Study of Bramitob®, a Tobramycin Solution for Nebulization, in Comparison with Tobi® Gianluigi PoliDaniela AcerbiIrmgard Eichler Original Research Article 24 August 2012 Pages: 3 - 9
Efficacy, Safety, and Local Pharmacokinetics of Highly Concentrated Nebulized Tobramycin in Patients with Cystic Fibrosis Colonized with Pseudomonas aeruginosa Gerard LenoirYuriy Genadievich AntypkinNikolay Leonidovich Aryayev Original Research Article 24 August 2012 Pages: 11 - 20
A Formulation of Aerosolized Tobramycin (Bramitob®) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection Alexander ChuchalinEszter CsiszérHenryk Mazurek Original Research Article 24 August 2012 Pages: 21 - 31